A detailed history of Mcdaniel Terry & CO transactions in Novartis Ag stock. As of the latest transaction made, Mcdaniel Terry & CO holds 6,190 shares of NVS stock, worth $608,786. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,190
Previous 5,820 6.36%
Holding current value
$608,786
Previous $620,000 14.84%
% of portfolio
0.06%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$106.13 - $120.89 $39,268 - $44,729
370 Added 6.36%
6,190 $712,000
Q2 2024

Aug 05, 2024

SELL
$92.57 - $107.37 $15,181 - $17,608
-164 Reduced 2.74%
5,820 $620,000
Q1 2024

Apr 29, 2024

SELL
$95.27 - $108.47 $526,557 - $599,513
-5,527 Reduced 48.01%
5,984 $579,000
Q2 2023

Jul 21, 2023

SELL
$92.52 - $104.91 $1,110 - $1,258
-12 Reduced 0.1%
11,511 $1.16 Million
Q1 2023

May 05, 2023

SELL
$80.03 - $92.81 $14,005 - $16,241
-175 Reduced 1.5%
11,523 $1.06 Million
Q4 2022

Jan 23, 2023

SELL
$75.55 - $92.52 $44,574 - $54,586
-590 Reduced 4.8%
11,698 $1.06 Million
Q3 2022

Oct 06, 2022

SELL
$74.61 - $87.26 $35,290 - $41,273
-473 Reduced 3.71%
12,288 $934,000
Q2 2022

Jul 28, 2022

SELL
$80.52 - $93.75 $471,927 - $549,468
-5,861 Reduced 31.47%
12,761 $1.08 Million
Q1 2022

Apr 27, 2022

SELL
$80.11 - $90.62 $12 Million - $13.6 Million
-150,080 Reduced 88.96%
18,622 $1.63 Million
Q4 2021

Jan 20, 2022

SELL
$79.7 - $88.13 $3.49 Million - $3.86 Million
-43,773 Reduced 20.6%
168,702 $14.8 Million
Q3 2021

Dec 06, 2021

BUY
$81.78 - $95.14 $527,889 - $614,128
6,455 Added 3.13%
212,475 $17.4 Million
Q2 2021

Aug 11, 2021

BUY
$85.24 - $94.15 $243,871 - $269,363
2,861 Added 1.41%
206,020 $18.8 Million
Q1 2021

May 17, 2021

BUY
$83.5 - $98.47 $174,515 - $205,802
2,090 Added 1.04%
203,159 $17.4 Million
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $310,796 - $375,925
3,981 Added 2.02%
201,069 $19 Million
Q3 2020

Nov 09, 2020

BUY
$82.14 - $91.0 $76,718 - $84,994
934 Added 0.48%
197,088 $17.1 Million
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $409,991 - $461,512
-5,066 Reduced 2.52%
196,154 $17.1 Million
Q1 2020

May 08, 2020

BUY
$70.67 - $99.01 $431,157 - $604,060
6,101 Added 3.13%
201,220 $16.6 Million
Q4 2019

Feb 03, 2020

SELL
$84.35 - $95.37 $147,106 - $166,325
-1,744 Reduced 0.89%
195,119 $18.5 Million
Q3 2019

Nov 07, 2019

SELL
$85.54 - $94.26 $204,868 - $225,752
-2,395 Reduced 1.2%
196,863 $17.1 Million
Q2 2019

Aug 12, 2019

BUY
$75.4 - $92.8 $103,147 - $126,950
1,368 Added 0.69%
199,258 $18.2 Million
Q1 2019

May 09, 2019

BUY
$75.32 - $86.15 $56,791 - $64,957
754 Added 0.38%
197,890 $0
Q4 2018

Feb 07, 2019

SELL
$73.66 - $82.02 $49,425 - $55,035
-671 Reduced 0.34%
197,136 $16.9 Million
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $45,318 - $52,420
677 Added 0.34%
197,807 $17 Million
Q2 2018

Aug 13, 2018

BUY
$64.91 - $73.36 $130,988 - $148,040
2,018 Added 1.03%
197,130 $14.9 Million
Q1 2018

May 11, 2018

SELL
$70.39 - $84.15 $31,253 - $37,362
-444 Reduced 0.23%
195,112 $15.8 Million
Q4 2017

Feb 09, 2018

SELL
$72.33 - $77.64 $40,432 - $43,400
-559 Reduced 0.29%
195,556 $16.4 Million
Q3 2017

Nov 13, 2017

SELL
$74.14 - $77.27 $411,477 - $428,848
-5,550 Reduced 2.75%
196,115 $16.8 Million
Q2 2017

Aug 10, 2017

BUY
N/A
201,665
201,665 $16.8 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mcdaniel Terry & CO Portfolio

Follow Mcdaniel Terry & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdaniel Terry & CO, based on Form 13F filings with the SEC.

News

Stay updated on Mcdaniel Terry & CO with notifications on news.